NX-5948
NX-5948-201
Phase 2 small_molecule active
Quick answer
NX-5948 for Chronic Lymphocytic Leukemia (CLL) is a Phase 2 program (small_molecule) at Nurix Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Nurix Therapeutics
- Indication
- Chronic Lymphocytic Leukemia (CLL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active